Analytical Data
-
基因名
PLCXD1
- Application
-
别名
FLJ11323; LL0XNC01-136G2.1; Phosphatidylinositol specific phospholipase C X domain containing 1 ; Phosphatidylinositol specific phospholipase C X domain containing protein 1; PI PLC X domain containing protein 1; PI-PLC X domain-containing protein 1; PLCX1_HUMAN; Plcxd1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NUJ7
-
表达区间
1-323 aa
-
氨基酸序列
MGGQVSASNS FSRLHCRNAN EDWMSALCPR LWDVPLHHLS IPGSHDTMTY CLNKKSPISH EESRLLQLLN KALPCITRPV VLKWSVTQAL DVTEQLDAGV RYLDLRIAHM LEGSEKNLHF VHMVYTTALV EDTLTEISEW LERHPREVVI LACRNFEGLS EDLHEYLVAC IKNIFGDMLC PRGEVPTLRQ LWSRGQQVIV SYEDESSLRR HHELWPGVPY WWGNRVKTEA LIRYLETMKS CGRPGGLFVA GINLTENLQY VLAHPSESLE KMTLPNLPRL SAWVREQCPG PGSRCTNIIA GDFIGADGFV SDVIALNQKL LWC
-
分子量
36.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PLCXD1 (Phospholipase C X-Linked Domain Containing 1) is a relatively obscure member of the phospholipase C (PLC) family, which plays a crucial role in various cellular processes, including signal transduction, cell proliferation, and differentiation. The study of PLCXD1 has gained attention due to its potential involvement in pathophysiological conditions, particularly in the context of cancer and other diseases linked to altered cellular signaling pathways. Recent research suggests that PLCXD1 may have a role in modulating pathways associated with cell survival and apoptosis, making it a promising target for therapeutic interventions. Furthermore, the recombinant protein of PLCXD1 is essential for elucidating its biochemical properties, interactions, and functional significance in cellular models. By producing and characterizing PLCXD1 as a recombinant protein, researchers can investigate its enzymatic activity, substrate specificity, and biological functions, thereby contributing to a deeper understanding of its role in health and disease. This knowledge could pave the way for the development of novel strategies in treating diseases where PLCXD1 is implicated, highlighting the importance of recombinant protein studies in the field of molecular biology and pharmacology.
